← FDA ENFORCEMENT
D-1103-2023Class III

Baxter Healthcare Corporation

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Baxter Healthcare Corporation
Product type
Drug
Status
Completed
Report date
2023-08-30
Distribution
Nationwide in the U.S.A.
Firm state
IL
Product quantity
13,502 vials
Initiated by
Voluntary: Firm initiated
Reason for recall

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Product description

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Code / lot info

Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →